微管蛋白靶向剂

William N. Hait , Eric Rubin , Elizabeth Alli , Susan Goodin
{"title":"微管蛋白靶向剂","authors":"William N. Hait ,&nbsp;Eric Rubin ,&nbsp;Elizabeth Alli ,&nbsp;Susan Goodin","doi":"10.1016/j.uct.2006.10.001","DOIUrl":null,"url":null,"abstract":"<div><p>Drugs<span><span> that target tubulin, including the vinca alkaloids and </span>taxanes<span><span>, represent some of the most effective anticancer medications. Both natural-product and semisynthetic compounds show a remarkable spectrum of </span>anticancer activity<span><span>. In this chapter, we review new developments in cancer biology and pharmacology that shed light on the effectiveness of tubulin binding agents. In addition, we highlight newer agents and several drugs in </span>preclinical development that hold considerable promise for the future. Finally, we comment on the rational selection of patients for chemotherapy and a more mechanistic approach to using these drugs in combinations.</span></span></span></p></div>","PeriodicalId":87487,"journal":{"name":"Update on cancer therapeutics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uct.2006.10.001","citationCount":"52","resultStr":"{\"title\":\"Tubulin Targeting Agents\",\"authors\":\"William N. Hait ,&nbsp;Eric Rubin ,&nbsp;Elizabeth Alli ,&nbsp;Susan Goodin\",\"doi\":\"10.1016/j.uct.2006.10.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Drugs<span><span> that target tubulin, including the vinca alkaloids and </span>taxanes<span><span>, represent some of the most effective anticancer medications. Both natural-product and semisynthetic compounds show a remarkable spectrum of </span>anticancer activity<span><span>. In this chapter, we review new developments in cancer biology and pharmacology that shed light on the effectiveness of tubulin binding agents. In addition, we highlight newer agents and several drugs in </span>preclinical development that hold considerable promise for the future. Finally, we comment on the rational selection of patients for chemotherapy and a more mechanistic approach to using these drugs in combinations.</span></span></span></p></div>\",\"PeriodicalId\":87487,\"journal\":{\"name\":\"Update on cancer therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.uct.2006.10.001\",\"citationCount\":\"52\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Update on cancer therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1872115X06000703\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Update on cancer therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1872115X06000703","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 52

摘要

针对微管蛋白的药物,包括长春花生物碱和紫杉烷,代表了一些最有效的抗癌药物。天然产物和半合成化合物都显示出显著的抗癌活性。在本章中,我们回顾了癌症生物学和药理学的新进展,阐明了微管蛋白结合剂的有效性。此外,我们强调了在临床前开发中具有相当前景的新药和几种药物。最后,我们评论了合理选择化疗患者和更机械的方法来使用这些药物联合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Tubulin Targeting Agents

Drugs that target tubulin, including the vinca alkaloids and taxanes, represent some of the most effective anticancer medications. Both natural-product and semisynthetic compounds show a remarkable spectrum of anticancer activity. In this chapter, we review new developments in cancer biology and pharmacology that shed light on the effectiveness of tubulin binding agents. In addition, we highlight newer agents and several drugs in preclinical development that hold considerable promise for the future. Finally, we comment on the rational selection of patients for chemotherapy and a more mechanistic approach to using these drugs in combinations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信